In the past week, VMD stock has gone up by 3.47%, with a monthly gain of 5.30% and a quarterly surge of 1.13%. The volatility ratio for the week is 3.18%, and the volatility levels for the last 30 days are 3.25% for Viemed Healthcare Inc The simple moving average for the past 20 days is 4.87% for VMD’s stock, with a -7.69% simple moving average for the past 200 days.
Is It Worth Investing in Viemed Healthcare Inc (NASDAQ: VMD) Right Now?
The price-to-earnings ratio for Viemed Healthcare Inc (NASDAQ: VMD) is above average at 23.97x. The 36-month beta value for VMD is also noteworthy at 1.34. There are mixed opinions on the stock, with 3 analysts rating it as a “buy”, 0 rating it as “overweight”, 0 rating it as “hold”, and 0 rating it as “sell”.
The public float for VMD is 34.29M, and at present, short sellers hold a 1.14% of that float. The average trading volume of VMD on July 04, 2025 was 182.34K shares.
VMD stock’s latest price update
Viemed Healthcare Inc (NASDAQ: VMD) has seen a rise in its stock price by 0.99% in relation to its previous close of $7.08. However, the company has experienced a 3.47% gain in its stock price over the last five trading sessions. accessnewswire.com reported 2025-07-02 that LAFAYETTE, LA / ACCESS Newswire / July 2, 2025 / Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has completed the previously disclosed acquisition of Illinois-based Lehan’s Medical Equipment (“Lehan”) for a base purchase price of $26 million, subject to customary adjustments, plus estimated contingent payments of $2.2 million. “We are pleased to close the acquisition of Lehan and bring this talented and highly motivated team into the Viemed family,” said Viemed Chief Executive Officer Casey Hoyt.
Analysts’ Opinion of VMD
Many brokerage firms have already submitted their reports for VMD stocks, with RBC Capital Mkts repeating the rating for VMD by listing it as a “Outperform”. The predicted price for VMD in the upcoming period, according to RBC Capital Mkts is $13 based on the research report published on March 05, 2021 of the previous year 2021.
VMD Trading at 4.83% from the 50-Day Moving Average
After a stumble in the market that brought VMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.12% of loss for the given period.
Volatility was left at 3.25%, however, over the last 30 days, the volatility rate increased by 3.18%, as shares surge +4.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.84% upper at present.
During the last 5 trading sessions, VMD rose by +3.47%, which changed the moving average for the period of 200-days by -5.80% in comparison to the 20-day moving average, which settled at $6.82. In addition, Viemed Healthcare Inc saw 11.72% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VMD starting from Moore Michael, who sold 177,830 shares at the price of $6.92 back on Jun 30 ’25. After this action, Moore Michael now owns 177,433 shares of Viemed Healthcare Inc, valued at $1,231,091 using the latest closing price.
Moore Michael, the President of Viemed Healthcare Inc, sale 3,486 shares at $7.00 during a trade that took place back on Jun 27 ’25, which means that Moore Michael is holding 177,433 shares at $24,402 based on the most recent closing price.
Stock Fundamentals for VMD
Current profitability levels for the company are sitting at:
- 0.08% for the present operating margin
- 0.59% for the gross margin
The net margin for Viemed Healthcare Inc stands at 0.05%. The total capital return value is set at 0.21%. Equity return is now at value 9.79%, with 7.38% for asset returns.
Based on Viemed Healthcare Inc (VMD), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at 6.03. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is 23.87.
Currently, EBITDA for the company is 42.31 million with net debt to EBITDA at -0.09. When we switch over and look at the enterprise to sales, we see a ratio of 1.2. The receivables turnover for the company is 8.69for trailing twelve months and the total asset turnover is 1.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.38.
Conclusion
In summary, Viemed Healthcare Inc (VMD) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
